These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38151613)

  • 21. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
    Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
    Front Genet; 2023; 14():1124439. PubMed ID: 36936439
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma.
    Ji ZH; Ren WZ; Wang HQ; Gao W; Yuan B
    Front Oncol; 2022; 12():919083. PubMed ID: 35875087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.
    Chen Y; Tang L; Huang W; Abisola FH; Zhang Y; Zhang G; Yao L
    Biol Direct; 2023 Feb; 18(1):4. PubMed ID: 36750831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response.
    Ma YL; Yang YF; Wang HC; Yang CC; Yan LJ; Ding ZN; Tian BW; Liu H; Xue JS; Han CL; Tan SY; Hong JG; Yan YC; Mao XC; Wang DX; Li T
    Front Pharmacol; 2023; 14():1101749. PubMed ID: 36909185
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
    Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
    Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
    Chen X; Hu G; Xiong L; Xu Q
    Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
    [No Abstract]   [Full Text] [Related]  

  • 28. Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas.
    Feng S; Zhang Y; Zhu H; Jian Z; Zeng Z; Ye Y; Li Y; Smerin D; Zhang X; Zou N; Gu L; Xiong X
    CNS Neurosci Ther; 2024 Feb; 30(2):e14380. PubMed ID: 37515314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.
    Tian XM; Xiang B; Yu YH; Li Q; Zhang ZX; Zhanghuang C; Jin LM; Wang JK; Mi T; Chen ML; Liu F; Wei GH
    Front Immunol; 2022; 13():999849. PubMed ID: 36211401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.
    Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X
    Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative analysis of the cuproptosis-related gene ATP7B in the prognosis and immune infiltration of IDH1 wild-type glioma.
    Zhang K; Qu C; Zhou P; Yang Z; Wu X
    Gene; 2024 May; 905():148220. PubMed ID: 38286269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
    Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P
    Front Immunol; 2022; 13():948042. PubMed ID: 36275737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis-related classification and personalized treatment in lower-grade gliomas to prompt precise oncology.
    Shen N; Chen S; Liu D; Min X; Tan Q
    J Gene Med; 2023 Jun; 25(6):e3486. PubMed ID: 36814111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
    Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
    Front Genet; 2023; 14():1094793. PubMed ID: 36891150
    [No Abstract]   [Full Text] [Related]  

  • 35. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas.
    Chen P; Han H; Wang X; Wang B; Wang Z
    Mediators Inflamm; 2023; 2023():6232620. PubMed ID: 36814682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics.
    Zhang Z; Wang B; Xu X; Xin T
    Front Genet; 2022; 13():1036460. PubMed ID: 36386799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer.
    Huang Y; Yin D; Wu L
    Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.